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-Adaptin Appendage Domain: Structure
and Binding Site for Eps15 and -Synergin
network (TGN) [13, 14] and endosomes [15] and is be-
lieved to mediate trafficking between TGN and the
endosomal system, whereas AP2 is found in plasma
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1MRC Laboratory of Molecular Biology membrane clathrin-coated pits (CCPs) and functions in
clathrin-mediated endocytosis (CME) [14, 16]. All APHills Road
Cambridge CB2 2QH complexes are heterotetramers comprised of two large
(100–130 kDa) adaptin subunits, which can be subdi-United Kingdom
2 INSERM Emi 0212 vided into a trunk domain (65–70 kDa) and an appendage
or ear domain (15–35 kDa) linked by an extended flexibleFaculte´ Necker-Enfants Malades
156, rue de Vaugirard linker or hinge (see Figure 1D), a medium adaptin subunit
of approximately 50 kDa, and a small adaptin subunit75730 Paris Cedex 15
France of 15–17 kDa (reviewed in [11]). Various functions have
been ascribed to different domains of AP complex sub-
units. The Yxxφ tyrosine-based sorting signals bind to
the medium ( subunit) [9, 17] while the D/ExxxLL dileu-Summary
cine-based motifs may bind to the trunks of the  sub-
units [18] and/or the medium chains [19]. In the case ofThe AP1 complex is one of a family of heterotetrameric
clathrin-adaptor complexes involved in vesicular traf- AP2, the  trunk binds to phospholipid headgroups [6,
10]). Clathrin interacts, via its terminal domain, withficking between the Golgi and endosomes. The com-
plex has two large subunits,  and 1, which can be LφnφD/E clathrin box motifs in the hinge regions of -
and -adaptins [8, 20–22]. The appendage domains ofdivided into trunk, hinge, and appendage domains.
The 1.8 A˚ resolution structure of the  appendage is AP2  and 2 subunits recruit a number of proteins that
perform accessory/regulatory roles in CCV biogenesis:presented. The binding site for the knownappendage
ligand -synergin is mapped through creation of point these include Eps15, epsin, AP180, auxilin, and the am-
phiphysins [23–27]. The three-dimensional structures ofmutations designed on the basis of the structure. We
also show that Eps15, a protein believed to be involved the  and 2 appendage domains have been solved and
have lead to an understanding of how they interact within vesicle formation at the plasma membrane, is also
a ligand of  appendage and binds to the same site their binding partners [25, 26, 28]. Less is known of the
exact roles of the large subunit appendage domains ofas -synergin. This observation explains the demon-
strated brefeldinA (BFA)-sensitive colocalization of the AP1 adaptor complex. Several candidate binding
partners have been identified for the  appendage,Eps15 and AP1 at the Golgi complex.
which include the EH domain-containing protein -syn-
ergin [29]. The appendage domain of  is approximatelyIntroduction
half the size (120 amino acids) of the other appendage
domains (250–300 amino acids) (see Figure 1). DomainsTransmembrane proteins and phospholipids are traf-
ficked between intracellular compartments and the of similar sequence have been recently identified in an-
other set of proteins termed the GGAs (Golgi localizedplasma membrane in carrier vesicles. Once the appro-
priate cargo has been sorted and concentrated into a gamma ear containing ARF1 binding proteins), which
are involved in vesicle coat formation and have beenforming vesicle, the vesicle buds from the donor mem-
brane and is transported to, and then fuses with, the implicated in trafficking between the TGN and endo-
somes [30–32].target membrane. One of the major classes of transport
vesicles is the clathrin-coated vesicle (CCV) in which Here we present the structure of a part of the AP1
adaptor complex—the -adaptin appendage domainthe phospholipid bilayer envelope is surrounded by a
scaffold comprised of the protein clathrin. These two determined by X-ray crystallography at 1.8 A˚ resolution.
It is an eight-stranded  sandwich similar to the N-ter-layers are linked by adaptor molecules that can crosslink
clathrin directly with integral membrane protein cargo minal subdomain of the  appendage [25] with which it
has 12% sequence identity on the basis of a structuralas in the case of the GGAs [1–4] or with phospholipid
headgroups, e.g., AP180 and epsin [5, 6] or simultane- alignment (see Figure 1D). In the  appendage this do-
main has no function assigned to it other than correctlyously with both as with the heterotetrameric AP com-
plexes [7–10]. presenting the C-terminal, protein binding “platform”
subdomain [28], and yet in the  appendage it performsFour distinct AP complexes have been identified in
higher eukaryotes (AP1, AP2, AP3, and AP4) and each the protein recruitment role. Structure-directed muta-
genesis was used to locate the binding site for the EHis believed to be associated with a different trafficking
pathway [11, 12]. AP1 is associated with the trans-Golgi domain-containing protein -synergin to a shallow hy-
drophobic trough formed where the two  sheets meet.
A second EH domain-containing protein Eps15, pre-3 Correspondence: djo30@cam.ac.uk
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Figure 1. Comparison of the Structures of the  and  Appendages
(A) Superposition of the C traces of  appendage (purple) and  appendage N-terminal subdomain (green). The two overlay with an rms
deviation of 1.8 A˚ for 96 C atoms.
(B) Schematic representation of the  appendage domain. Point mutations that abrogate binding to -synergin and Eps15 are shown in yellow
in ball and stick representation. All protein structure pictures were made using Aesop (M.E.M. Noble, personal communication).
(C) Schematic representation of the  appendage domain. The N-terminal subdomain is in green and the C-terminal subdomain in gold.
(D) Structure-based sequence alignment of  appendages from human, mouse, Arabidopsis, and smutfungus, mouse 2-appendage, human
GGA1 appendage, and the N-terminal subdomain of the  appendage. The positions of  strands are marked by arrows and  helices with
rods (purple human  appendage and green  appendage). Conserved residues are indicated by gray shading and residues identical between
the  and  appendages are marked with an asterisk.
(E) C trace of the  appendage in stereo representation.
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viously shown to be a major binding partner of the 
appendage, is shown to bind to the same site on the 
appendage as -synergin. The interaction of  append-
age with Eps15 explains the BFA-sensitive colocaliza-
tion of Eps15 and AP1 at the Golgi network, which we
demonstrate by immunofluorescence.
Results
Structure of the -Adaptin Appendage Domain
Sequence alignment programs failed to produce a sta-
tistically significant alignment of the  appendage do-
main with the entire sequences of  and 2 appendage
domains and secondary structure prediction gave no
obvious indication that the appendage was structurally
similar to either the amino or carboxy terminal subdo-
mains of  or 2 appendage domains. The structure of
the appendage domain of -adaptin (residues 704–822)
was therefore determined by X-ray crystallography by
isomorphous replacement at 1.8 A˚ resolution. The wild-
type protein crystallized in space group P212121 with
one molecule in the asymmetric unit. A single site xenon
derivative, a weak PtCl42 derivative, and solvent flat-
tening gave an excellent electron density map.
The structure of the -adaptin appendage domain is
an eight-stranded  sandwich (Figures 1A and 1E) com-
prised of one eight-stranded and one five-stranded 
sheet very similar to that of the amino-terminal subdo-
main of -adaptin (rms of 1.8 A˚ over 96 C; Figure 1A). Figure 2. Interaction of  Appendage with -Synergin and Eps15
The sheets are closer together at the edge where strands Purified, folded GST-fusion proteins corresponding to wild-type and
1 and 8 meet than at the edge where strands 4 and 5 mutant forms of  appendage,  appendage, and amphiphysin2
SH3 domain were used in pull-down experiments from rat brainmeet. On the basis of a superposition with the  and
cytosol (see Experimental Procedures). Wild-type and P728S (a con-2 appendage domains, the structure-based sequence
trol mutation distant from the binding site) bound to -synergin andalignment shown in Figure 1D was constructed. There
Eps15, whereas P765N showed reduced binding, and L762E and
are 13 residues conserved between the  appendage A753D showed no binding. No form of the  appendage bound
and the  appendage amino-terminal subdomain. Ten significantly to AP180, dynamin, or clathrin.
of these are involved in maintaining the architecture of
the fold. Of these, seven are amino acids with hydropho-
bic side chains, which pack the core of the sandwich,
 appendage. The appendage domains of  and  as
while the other three are vital in maintaining the back- N-terminal GST fusion proteins were used in pull-down
bone conformation of turns between strands. Compari- experiments, the results of which were probed with anti-
son of the available  appendage domain sequences bodies specific to known ligands of the various append-
from human, rodent, Arabidopsis, and fungus shows age domains (Figure 2; Table 2). The  appendage do-
conservation of residues mainly within the  strands. main was confirmed to interact with Eps15, AP180, and
The notable exception is the sequence QAAVPK in the also weakly with clathrin (Figure 2) but not with dynamin
loop between strands 4 and 5, which is identical in all (Figure 2 and [25, 28]) or the 110 kDa -synergin (Figure
the  appendage sequences as well as in that of the 2). The  appendage domain binds to -synergin as
GGA appendages (Figure 1D). expected [29] but not significantly to clathrin (which has
been proposed to be a direct ligand for the  hinge [22]),
AP180, the amphiphysins, or dynamin. However, it wasFunction of  Appendage Domain
Comparison of the  and  appendage structures shows able to bind to the largest of the four Eps15 isoforms
present in brain, all of which bind to the  appendage.that the  appendage lacks the platform subdomain
present in the  appendage. This platform subdomain The  appendage binds its partners with high micro-
molar dissociation constant (as estimated from the lowcontains the single site through which the  appendage
binds to all of its known ligands. The N-terminal sand- stoichiometry of ligand to appendage present in GST
pull-down experiments when assayed by Coomassiewich subdomain of the - and 2-adaptins have no func-
tion assigned to them other than correctly presenting blue staining; data not shown). This is a similar affinity
to that of the  and 2 appendages for their bindingthe platform protein/protein interaction subdomain.
Since the  appendage domain functions as a protein partners [25, 26], so a similar binding mode through the
recognition of a short peptide motif would be expected.recruitment module [29], it was surprising that it resem-
bled the N-terminal  sandwich subdomain rather than The surface was therefore inspected for suitable sites
that could accommodate a short peptide motif andC-terminal protein binding platform subdomain of the
Structure
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Table 1. Binding of Ligands to Wild-Type and Mutant  Appendages
-Synergin Eps15 Clathrin AP180 DynaminI
 appendage  
P728S  
A753D
L762E
P765N  
 appendage /   
Amph2 SH3 
Summary of data from pull-down experiments using GST-fusion proteins of wild-type and mutant forms of the  appendage,  appendage,
and the amphiphysin2 SH3 domain. The degree of binding is indicated by the number of  symbols (no binding above background is indicated
by ). The results shown are the average of eight independent experiments. P728 is distant from the binding site, and the mutant P728S is
included as a control. Other mutations which show wild-type binding behavior are: N713W, R723E, V749N, Q751S, V754T, K756E, Q759H,
L760Q, L763E, S764A, S768A, Y800F, H802S, L810P, and W821G. Mutation in Q780 to A, K, or N cause unfolding.
had at least moderate hydophobic surface potential N-terminal GST fusion proteins were used in pull-down
experiments from brain cytosol; the results of which[25]. Unlike the situation with the  and  appendages,
no obvious site of high-hydrophobic potential was were probed with antibodies against -synergin and AP2
ligands as described above (Figure 2; and summarizedrevealed.
A variety of point mutations were made on the basis in Table 1). Two point mutations were identified that
prevented binding of -synergin and Eps15 (A753D andof the structure, mainly in surface residues that did not
appear to be involved in maintaining the integrity of the L762E) and one that reduced their binding (P765N).
These mutations map to a shallow trough lined withprotein fold (see complete list in the legend to Table 1,
illustrated in Figure 3A). The mutants were made as mainly hydrophobic residues on the surface formed
where  strand 4 from the three-stranded sheet andN-terminal GST fusion proteins, the GST proteolytically
cleaved, and the fold of each resulting  appendage strand 5 from the five-stranded sheet meet (as shown
in Figures 3A and 3B). In the center of this trough theredomain was tested by circular dichroism (data not
shown). All were folded except mutations in Q780, which is a small hydrophobic pocket lined by the side chains
of L762, L760, and I782. The effects of the mutationsresulted in insoluble protein. This residue is conserved
between  and  appendages, and the effect of mutating at the molecular level were probed by crystallizing the
mutant forms of the protein. The mutant L762E crystal-it may be explained by the partial burial of the hydrophilic
side chain of this residue (Figure 3A). The folded lized in the same crystal form as the native  appendage
Figure 3. Mutations L762E and A753D Abol-
ish Ligand Binding but Do Not Effect the Fold
of  Appendage
(A) Schematic representation of  appendage
with all the side chains that were mutated
shown in ball and stick representation. Muta-
tions that cause altered binding of -synergin
and Eps15 are colored bright green (abolition
of binding), pale green (partial binding), and
no effect (uncolored). Q780, which unfolds
the protein, is colored blue.
(B) Surface representation of  appendage
calculated using Aesop (M.E.M. Noble, per-
sonal communication) to show the hydropho-
bic trough between strands 4 and 5. Muta-
tions are colored according to the effect of
the mutation on -synergin/Eps15 binding as
in (A).
(C–E) The L762E mutation causes the small
hydrophobic pocket formed by L760, L762,
and I782 to become blocked. The wild-type
 appendage structure is shown with carbon
atoms in white (C and D) and the L762E mu-
tant structure with carbon atoms in green (D
and E). (D) is a superposition of wild-type and
L762E. (C)–(E) are taken from the same view-
point.
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Role of AP1 In Vivo
Is the interaction of the  appendage with Eps15, which
has been demonstrated in vitro (see above), relevant in
vivo? It has been previously reported that, in addition
to its colocalization with AP2 at the plasma membrane,
Eps15 shows some perinuclear staining that is sensitive
to nocodazole treatment [33, 34]. These results sug-
gested a possible dual localization of Eps15 to plasma
membrane CCPs and clathrin-coated regions of the
Golgi, i.e., the TGN. To test this hypothesis, HeLa cells
were fixed and stained for Eps15 (Figures 4A and 4B)
and both AP1 and AP2 (Figures 4C and 4D) using an
antibody against 1- and 2-adaptins. Eps15 showed
a complete colocalization with punctate plasma mem-
brane-associated AP2 (CCPs) and significant colocali-
zation with perinuclear Golgi AP1 staining (TGN) (see
insets Figure 4). The Eps15/AP1 colocalization is further
demonstrated by the amount of yellow coloration at the
Golgi in the merged image (Figure 5C) of Eps15 (Figure
5A, red) and AP1 (Figure 5B, green) obtained by confocalFigure 4. Eps15 Is Present on the Plasma Membrane and the Golgi
microscopy. The additional peripheral red punctateHeLa cells were fixed, permeabilized, and processed for immunoflu-
staining for Eps15 is due to the presence of Eps15 inorescence microscopy using a rabbit affinity-purified anti-Eps15
CCPs at the plasma membrane. The same staining andpolyclonal antibody (A and B) and the anti--adaptins monoclonal
mouse antibody 100.1 (C and D), revealed by Alexa 594-labeled colocalization pattern was observed using GFP-tagged
anti-rabbit immunoglobulins and Alexa 488-labeled anti-mouse im- Eps15 constructs (data not shown) confirming that TGN
munoglobulins secondary antibodies. Cells were observed under staining of Eps15 was not due to cross-reactivity of the
an epifluorescence microscope attached to a cooled CCD camera.
antibodies with a related EH-domain-containing protein.In (A) and (C), the focus was made on the planar plasma membrane
AP1 is recruited to membranes through its interactionadherent to the coverslip to better observe CCPs. In (B) and (D),
with the small GTPase ARF1 only when ARF1 is in itsthe focus was made on the central region of the cell to better observe
the Golgi apparatus. The same field is shown (A)–(D). In (B) and (D), membrane-associated GTP-bound form. The exchange
insets show a higher magnification (2) of the portions of cells of GDP for GTP on ARF1 is catalyzed by a guanine
included in the open squares. nucleotide exchange factor (GEF). BFA causes dissocia-
tion of AP1 from membranes through its ability to inter-
fere with the GEF catalyzed GDP/GTP nucleotide ex-
domain, whereas the A753D crystallized in the space change on ARF1 [35]. If proteins such as -synergin and
group P41212 with two rather than one molecule in the Eps15 that do not bind to ARF1 show BFA-sensitive
asymmetric unit. There are no significant movements in membrane localization, it must be because they interact
the peptide backbones of either mutant directly caused with an ARF1 binding adaptor protein/protein complex
by the mutations. such as AP1. The effect of BFA treatment on the localiza-
In the case of the L762E mutation, the glutamate side tion of Eps15 was therefore investigated (Figure 6). Cells
chain moves to allow its carboxyl group to point into were treated with ethanol (Figures 6A–6C) or BFA (Fig-
solvent and results in the pocket created by L762, L760, ures 6C–6E), and the staining for Eps15 (Figures 6A, 6B,
and I782 becoming filled (Figure 3). The side chain of 6D, and 6E) and AP1 (Figures 6C and 6F ) was studied
residue L760 has moved more into the core of the protein using confocal microscopy focusing on the Golgi (Fig-
in order to try and compensate for the loss of the L762 ures 6B, 6C, 6E, and 6F) or the plasma membrane (Fig-
side chain from this region. The A753D mutant shows ures 6A and 6D). Eps15 Golgi staining is lost in the same
no significant changes in the side chains that make up way as staining for AP-1 (Figures 6B, 6C, 6E, and 6F),
which is consistent with the localization of Eps15 beingthe small hydrophobic pocket (data not shown).
Figure 5. Colocalization of Eps15 and AP1 at
the Golgi
HeLa cells were fixed, permeabilized, and
processed for immunofluorescence micros-
copy using the affinity purified anti-Eps15 an-
tibody (A) and the anti--adaptin mouse
monoclonal antibody 100.3 (B), revealed by
an Alexa 594-labeled anti-rabbit immuno-
globulins and an Alexa 488-labeled anti-
mouse immunoglobulins secondary antibod-
ies. Cells were observed under a confocal
microscope. A medial optical cut of represen-
tative cells is shown. Areas of colocalization
appear yellow in the computer-generated
composite image (C).
Structure
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Figure 6. Eps15 Localization at the Golgi is
BrefeldinA Sensitive
Ethanol- (A–C) and BFA- (D–F) treated HeLa
cells were fixed and processed for immuno-
fluorescence microscopy using the poly-
clonal affinity-purified anti-Eps15 antibody (A
and B, and D and E) and the anti--adaptin
monoclonal mouse antibody 100.3, revealed
by an Alexa 488-labeled anti-rabbit immuno-
globulins and an Alexa 594-labeled anti-mouse
immunoglobulins secondary antibodies. Cells
were observed under an epifluorescence mi-
croscope attached to a CCD camera. The same
field is shown in (A)–(C), and in (D)–(F). In (A)
and (D), the focus was made on the planar
plasma membrane adherent to the coverslip
to better observe CCPs. In (B)–(F), the focus
was made on the central region of the cell to
better observe the Golgi appartus. In (B) and
(C), insets show a higher magnification (2)
of the portions of cells included in squares.
due to its interaction with AP1. A similar scenario for the residues conserved between the - and -adaptin
appendages are involved in maintaining the architecturethe BFA sensitivity of -synergin staining has been dem-
onstrated [29]. In contrast to the Golgi staining of Eps15, of the fold either by packing the hydrophobic interior
of the protein or maintaining structure in turns. This plasma membrane CCP staining of Eps15 is not per-
turbed by BFA treatment (Figures 6A and 6D), as pre- sandwich domain is shown to have a protein binding
function in the  appendage, mediated by a shallowviously reported for AP2, since AP2 recruitment is not
BFA sensitive [35]. hydrophobic groove formed where the two sheets meet.
The requirement that interactions between appendage
domains and their ligands be transient, with Kds in theDiscussion
high micromolar range, means that they are likely to
involve a short peptide binding to a folded domain. TheThe structure of the -adaptin appendage domain is very
nature of the binding site, namely a shallow hydrophobicsimilar to that of the -adaptin N-terminal subdomain
trough surrounded by charged (mainly basic) residues,despite only 12% sequence identity: this similarity was
is in line with this mode of interaction. This type of sitedetectable only after structure determination. Most of
is also found in the  and 2 appendage domains, which
bind to DφF motifs [25, 26, 28], and in EH domains,
which bind to NPF motifs [36]. All of the mutations
(L762E, P765N, and A753D) alter the chemical properties
of this potential binding site, in all cases making it less
hydrophobic, which argues that a substantial part of the
interaction will be mediated by hydrophobic side chain
interactions. The L762E mutation also results in the fill-
ing in of the small hydrophobic cavity between L762
and L760, which would be a good candidate for the
interaction site for a hydrophobic side chain. This small
pocket does not have a high hydrophobic potential, as
do the DφF binding pockets in the  and 2 appendages
[25, 26], due to the presence of the backbone amide of
residues A752 and K756 and the backbone carbonyl of
residue A752. These backbone groups may well interact
with the backbone of the motif on -synergin/Eps15 to
which the  appendage binds. It is also interesting to
note that the mutations that have the largest effects on
ligand binding both increase the local negative charge
around the binding site on the  appendage, suggesting
that the interaction may also involve recognition of a
negative charge on the target proteins. The N-terminal
 sandwich domains in the  and 2 appendages have
different surface characteristics from the  appendage
 sandwich domain, which argues that in these largerFigure 7. Role of  Appendage in AP1 Function
appendages this domain does not play a protein/proteinThe  appendage recruits proteins including -synergin and Eps15,
interaction role.which may in turn recruit further proteins to aid in the formation of
AP1-containing CCVs. Did the  appendage lose its platform domain or did
 Appendage: Structure and Function
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Table 2. Statistics on Data Collection and Phasing
Data collectiona Native L762E
Resolution (A˚) (outer bin) 1.81 (1.91) 1.70 (1.80)
Rmergeb 0.062 (0.242) 0.062 (0.279)
Rmeasc 0.073 (0.285) 0.067 (0.305)
I	/
(I	)	 15.1 (5.1) 22.0 (6.0)
Completeness (%) 98.7 (92.2) 99.6 (97.9)
Multiplicity 3.7 (3.6) 6.4 (6.1)
Wilson plot B (A˚2 ) 20 20
MIR phasing Xe PtCl42
Number of sites 2 2
Rcullisd 0.60 0.90
Phasing power: isomorphous (anomalous)e 2.2 (1.1) 0.94 (0.76)
Mean figure of merit 0.36
Figure of merit after solvent flattening (all data) 0.92
Refinement Wild-type L762E
R (Rfree)f 0.175 (0.223) 0.178 (0.225)
B	 (A˚2) 23.5 21.2
Nreflections (Nfree) 10724 (1164) 12740 (1408)
Natoms (Nwater) 1114 (171) 1135 (191)
Rmsd bondlength (A˚) 0.032 0.021
Rmsd angle () 2.2 1.9
Estimated coordinate error from Rfree (A˚) 0.135 0.118
Number of Ramachandran violations 0 0
a Values in brackets apply to the high-resolution shell.
b Rmerge  i|Ih  Ihi|/iIh, where Ih is the mean intensity for reflection h.
c Rmeas  (n/n  1)i|Ih  Ihi|/iIh, the multiplicity weighted Rmerge (Diederichs and Karplus, 1997).
d Rcullis  ||FPH  FP|  |FHcalc||/|FPH  FP|.
e Phasing power  |FHcalc|/phase-integrated lack of closure	.
f R  |FP  Fcalc|/FP.
other appendage domains acquire it? Structure determi- with the localization of proteins whose membrane bind-
ing is regulated by the small GTPase ARF1. AP1 hasnation (adaptin appendages from , 2, [25, 26, 28], and
 [unpublished data]) and sequence alignments (1, 3, been shown to bind to ARF1 [38], but neither -synergin
nor Eps15 bind to ARF1. The exact role played by eitherand  adaptin appendages, and COP and COP puta-
tive appendages) show the presence of large (30–35 -synergin or Eps15 is unclear but is most likely to be
in using their EH domains to recruit NPF-containing pro-kDa) two-subdomain appendages on these “large
adaptin subunits.” Since - and -adaptins are the most teins, including epsin and synaptojanin (reviewed in
[39]), needed for AP1-containing vesicle formation. Aclosely related of these large adaptin proteins (on the
basis of sequence alignments of their trunk domains), similar role has been proposed for Eps15 function in
CME at the plasma membrane. Obvious candidates forthat is they diverged from each other after the diver-
gence of the other large subunits [37], it seems probable recruitment by Eps15/-synergin at the Golgi would be
members of the epsin family, which may explain thethat the -adaptin once had a two-subdomain append-
age but lost its platform subdomain. The high degree of observation that there is a pool of epsin located at the
Golgi [24]. The  appendage functions as a site for re-sequence identity between the  and GGA appendages
(Figure 1D) [30–32] clearly points to these domains hav- cruitment of proteins that play accessory/regulatory
roles in AP1-containing CCV formation, which includeing evolved from a common single domain ancestor
more recently than the separation of -adaptin from -synergin and Eps15 and, in all probability, further pro-
teins that remain to be identified.-adaptin. The proposal that the appendage domains
of -adaptin, 2-adaptin, and the GGAs perform the
same functions, namely binding to the same protein Biological Implications
ligands, is supported by the very high degree of se-
quence identity between them in the binding site The structure of the AP1  appendage has a  sandwich
fold. It is therefore structurally similar to the N-terminal(QAAVPKxxxLQL) identified in this work (Figure 1D).
The ability of -synergin and the largest isoform of subdomains of the AP2  and 2 appendages, although
it performs the same function as the C-terminal subdo-Eps15 to bind to the appendage along with the colocal-
ization of AP1 and Eps15 (this work) and of AP1 and mains of these larger appendages, namely recruitment
of proteins that play accessory roles in CCV formation.-synergin [29], demonstrated by immunfluorescence
microscopy, suggests that these pairs of proteins inter- The binding site on the  appendage for the established
ligand -synergin is situated where the two sheets ofact in vivo. This is supported by the observation that the
Golgi localization of both these EH domain-containing the sandwich meet and is shown to be the same site
where the newly proposed ligand, Eps15, also binds.proteins is disrupted by BFA, a compound that interferes
Structure
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refined with REFMAC [45]. Hydrophobic interaction surface poten-Eps15 resembles -synergin in its BFA-sensitive colo-
tials were calculated as in [25] and displayed using Aesop (M.E.M.calization with AP1 at the Golgi, suggesting that Eps15
Noble, personal communication).functions at the Golgi as well as at the plasma membrane
where it is involved in CME. This indicates a general
Protein-Protein Binding Assays
role for Eps15 in CCV formation and therefore raises Binding assays were performed by incubating 20 g GST append-
questions about the use of Eps15 domains as specific age or GST amphiphysin2 SH3 domain or 30 g GST appendage
inhibitors of CME. Some of the proteins that interact with 0.5 ml of 0.1% TritonX-100 brain extract in buffer A in the
presence of 20 l 50% slurry of glutathione-sepharose at 4C fordirectly with the AP2 complex appendages, such as
1 hr. The beads were washed three times for 3 min with bufferA andEps15 and amphiphysin, also bind to other proteins,
the bound proteins analyzed by SDS PAGE followed by immunoblot-such as epsin, dynamin, and synaptojanin. The finding
ting. One fifth of each pull-down experiment was loaded on each
that both the ligands of theappendage contain protein/ lane, i.e., 4 g GST appendage. Antibodies used were: anti-AP180
protein interaction “EH” domains suggests that a simi- (NB29 Oncogene), anti-eps15 (C-20 Santa Cruz Laboratories), and
larly large network of proteins may be recruited during anti-clathrin heavy chain (TD1 Neomarkers), anti-dynamin (NB28
Oncogene), and anti--synergin (HMK1).both AP1- and AP2-containing CCV formation (Figure 7).
The identification of single point mutations that pre-
Immunofluorescencevent -synergin binding will be useful tools for investi-
HeLa cells (ATCC, Manassas, VA) were grown in Eagle’s mediumgating the function AP1 in vivo. The transfer of the L762E
modified by Dulbecco (DMEM), supplemented with 10% fetal calfand/or A753D mutations to full-length -adaptin so that
serum, 2 mM L-glutamine, penicillin, and streptomycin (GIBCO-
it is unable to interact with -synergin and Eps15 will BRL). For treatment with BFA (Sigma), HeLa cells grown on cov-
make it possible to investigate the role of these interac- erslips were incubated for 2 min at 37C with 5 g/ml BFA in DMEM
tions in AP1 function. The mutations described may or with a 1/2000 dilution of ethanol in DMEM as a control.
For immunofluorescence studies, cells grown on coverslips wereknock out the AP1 pathway, thus making it possible to
washed in PBS, fixed in a solution containing 3.7% paraformalde-demonstrate exactly which pathway(s) use AP1 as an
hyde and 30 mM sucrose, for 30 min at 4C. The cells were washedadaptor. Further, it should also allow the role of -syner-
once in PBS, and after quenching for 10 min in PBS containing 50
gin and Eps15 to be investigated. mM NH4Cl, washed again in PBS supplemented with 1 mg/ml BSA.
The cells were incubated with primary antibodies in permeabilization
Experimental Procedures buffer A (PBS containing 1 mg/ml BSA and 0.05% saponin) for 45
min at room temperature. After two washes in the same buffer A,
Constructs the cells were incubated for 45 min at room temperature in buffer
The cDNA encoding residues 704–822 of mouse -adaptin (the A containing the labeled secondary antibody. After two washes in
appendage domain) was cloned into the vector pGEX 4T2 for pro- buffer A and one in PBS, the cells were mounted on microscope
duction as an N-terminal GST fusion protein and into pET15b for slides in 100 mM Tris-HCl buffer (pH 8.5) containing 100 mg/ml
expression as an N-terminal hexaHis-tagged fusion. Mutants of  Mowiol (Calbiochem) and 25% glycerol (v/v).
appendage were made by PCR using primers incorporating the The samples were examined under an epifluorescence micro-
changed bases. scope (Axioplan II, Zeiss) attached to a cooled CCD-camera (Spot-2,
Diagnostic Instruments) or under a confocal microscope (LSM 510,
Protein Expression and Purification Zeiss).
GST-fusion protein for biochemical studies were expressed in DH5 Antibodies used were: monoclonal mouse antibodies 100.3
at 25C overnight and produced as in [25]. N-terminal His6-tagged against -adaptin and 100.1 against -adaptins (Sigma, [14]); affin-
fusion proteins for crystallization trials were grown in bacterial strain ity-purified rabbit polyclonal anti-Eps15 antibody [46]; Alexa 488
BL21DE3 pLysS at 25C overnight. The proteins were purified on a goat anti-mouse immunoglobulins; and Alexa 594-conjugated goat
Ni-NTA-agarose column (Qiagen) and bound protein was eluted with anti-rabbit immunoglobulins (Molecular Probes).
buffer A (0.2 M NaCl, 20 mM HEPES [pH 7], 4 mM -mercaptoetha-
nol) containing 0.3 M imidazole. The proteins were further purified
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P212121 with one molecule in the asymmetric unit, unit cell dimen-
sions a  34.1 A˚, b  54.8 A˚, and c  68.0 A˚. The mutant A753D
Received: February 21, 2002crystallized in the spacegroup P41212 with two molecules in the
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 b 62.2 A˚ and c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Accepted: May 13, 2002grown by hanging drop vapor diffusion against a reservoir containing
24% PEG4000, 100 mMTris (pH 8.0), and 200 mM MgCl2.
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